JucaBio
We are a team of experienced drug developers focused on designing efficient clinical development plans to quickly demonstrate the value of drugs that address significant unmet medical needs.
Series A ·
Amount not disclosed in a source on record.
Funding history ↓Signals
Website registeredMar 29, 2023 (3 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series A | undisclosed | — | fundraisingfox.com |
Timeline
- Website created
Founders and team
CP
Catherine Pearce CEO & foundersource: jucabio.comJT
Justin Thompson CBO & founderLinkedIn · source: jucabio.com
Companies like JucaBio
AAdcendo$75M Series B+ · Apr 2026
TTolerance Bio$17.2M Seed · Oct 2024KK2 Therapeutics$50M Seed · Aug 2026
AArnatar Therapeutics$50M Series A · Mar 2026
AAdcytherixSeries A · Oct 2025
CConfo Therapeutics$65M Series B+ · Aug 2024
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/jucabio (get a free API key).